Jason Karas

Senior Director, Commercial

Red Nucleus

Bio:

Jason is a Life Sciences Leader with 17+ years commercial strategic advisory experience spanning corporate strategy, portfolio strategy, go-to-market, and BD / M&A support. He brings extensive Rare Disease & Gene Therapy expertise with a focus on opportunity assessments and developing novel GTM strategies.

Sessions:

Speaker The Data Behind Successful Gene Therapy Launches: Best Practices for High-Engagement Assets